CClinicalTrials.gg
Active, not recruitingNCT05524727Updated Jan 18, 2024

PEMOCS: Personalized Motor-cognitive Training in Chronic Stroke

An interventional study of Concept-guided, personalized, motor-cognitive training by means of an exergame in Stroke, sponsored by University of Zurich. Active, not recruiting at 3 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-18.

Sponsored by University of Zurich · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 3 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In Switzerland, approximately 20'000 persons suffer a stroke each year. Despite carefully considered rehabilitation programs, full recovery is achieved only in a small proportion of stroke survivors (www.swissheart.ch). Studies suggest that motor-cognitive trainings can improve gait, balance, and mobility in chronic stoke survivors. However, little is known about the effect of motor-cognitive trainings on cognitive functioning in chronic stroke.

The aim of this study is to evaluate the effects of a motor-cognitive training added to usual care compared to usual care alone on cognitive functions, single- and dual-task mobility, gait and health-related quality of life.

In this single-blind RCT, 38 participants will be allocated randomly to either the intervention group (usual care + motor-cognitive training by means of an exergame for 12 weeks, 2x/week for 30-40 minutes) or the control group (usual care only). Both groups will attend three assessments, at baseline, post-intervention (12 weeks after baseline), and at follow-up (24 weeks after baseline). Global cognitive functioning will be the primary endpoint and a linear mixed model will be used for analysis.

Motor-cognitive trainings, especially exergames, bear the potential for further development of innovative long-term rehabilitation solutions for chronic stroke survivors. Cognitive deficits are a common unmet need restricting daily activities mentioned by chronic stroke survivors. Exergame training following personally tailored progression to generate optimal training load may help addressing this unmet need. Therefore, this study will contribute to the on-going research objective on how to improve the long-term care of stroke patients.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • cognition
  • gait
  • mobility
  • training
  • chronic stroke
  • rehabilitation
  • virtual reality
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 38 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults (> 18 years) with chronic stroke (≥ 6 months post-stroke)
  • Stroke: ischemic or haemorrhagic
  • Able to stand for 3 minutes and walk 10 meters, functional ambulation category ≥ 3
  • Able to follow a two-stage command
  • Able to give informed consent as documented by signature

Exclusion criteria

Exclusion Criteria:

  • Unable or not willing to give informed consent
  • Other neurological diseases (e.g. Parkinson's Disease, multiple sclerosis), except cognitive deficits or dementia
  • Clinical contra-indications for the study intervention
  • Unable to follow the study intervention or the test for the primary endpoint (MoCA), e.g. due to a neglect, aphasia or other language problems
  • Overlapping enrolment in another clinical trial
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Usual care + concept-guided, personalized, motor-cognitive training by means of an exergame

    Other: Concept-guided, personalized, motor-cognitive training by means of an exergame

  • No intervention
    Control Group

    Usual care only

Interventions

  • OtherConcept-guided, personalized, motor-cognitive training by means of an exergame

    12 weeks, two times per week for 30-40min

06

What researchers measure

Primary outcomes

  1. Change of Montreal Cognitive Assessment Score

    Widely used screening tool and cognitive outcome in neurological patients including stroke

    Time frame: week 0, week 12 and week 24

Secondary outcomes

  1. Change of Stroke Impact Scale 3.0 Score

    Stroke-specific measurement tool assessing patient-reported health-related quality of life

    Time frame: week 0, week 12 and week 24

  2. Change of Simple Reaction Test Parameters

    Widely used reliable and valid neuropsychological test assessing alertness

    Time frame: week 0, week 12 and week 24

  3. Change of Trail Making Test A & B Parameters

    Widely used reliable and valid neuropsychological test assessing processing speed and executive functions

    Time frame: week 0, week 12 and week 24

  4. Change of Stroop Interference Test Parameters

    Widely used reliable and valid neuropsychological test assessing the ability to inhibit the reaction to a more dominant stimulus in favour of the inquired reaction to a less dominant stimulus

    Time frame: week 0, week 12 and week 24

  5. Change of N-back test Parameters

    Widely used reliable and valid neuropsychological test assessing working memory and related cognitive functions

    Time frame: week 0, week 12 and week 24

  6. Change of Mental Rotation Test Parameters

    Measures the ability to mentally rotate abstract objects

    Time frame: week 0, week 12 and week 24

  7. Change in Single- and cognitive Dual-Task Timed Up and Go Test Parameters and motor/cognitive dual task costs

    Widely used, reliable and valid test of mobility and dual-task ability in various populations including stroke.

    Time frame: week 0, week 12 and week 24

  8. Change of 10 meter walk test Gait Parameters

    Widely used test to assess gait speed and spatiotemporal gait parameters.

    Time frame: week 0, week 12 and week 24

  9. Change of Outdoor Gait Parameters

    Assesses walking endurance and spatiotemporal gait parameters under daily-life conditions.

    Time frame: week 0, week 12 and week 24

Other outcomes

  1. Compliance Rate

    attended sessions / offered sessions

    Time frame: week 12

  2. Adherence Rate

    attended training time / offered training time

    Time frame: week 12

  3. Perceived Motor-Cognitive Task Difficulty

    visual analogue scale after each training session, based on cognitive load theory, scale from 1-9, where 9 symbolizes most difficult

    Time frame: twice per week, week 0-12

  4. Perceived Performance

    visual analogue scale after each training session, performance item of the National Aeronautics and Space Administration - Task Load Index, scale from 0 to 20, where 20 symbolizes highest performance

    Time frame: twice per week, week 0-12

  5. Dose and Content of Usual Care

    according to weekly questionnaire, based on TIDIeR checklist

    Time frame: once per week, week 0-24

  6. Amount and Intensity of General Physical and Cognitive Activity

    according to weekly questionnaire, based on TIDIeR checklist

    Time frame: once per week, week 0-24

07

Study locations

3 sites
  • Kantonsspital Winterthur
    Winterthur, Zurich 8400, Switzerland
  • Ambulante Reha Triemli Zürich
    Zurich, 8063, Switzerland
  • University Hospital Zürich
    Zurich, 8091, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05524727
Lead sponsor
University of Zurich
Responsible party
Sponsor
First posted
Sep 1, 2022
Start date
Sep 1, 2022
Primary completion
Jul 2024 (estimated)
Completion
Jul 2024 (estimated)
Last update
Jan 18, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion